These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 3296611)
21. Drug resistance in Nepali leprosy patients. Butlin CR; Neupane KD; Failbus SS; Morgan A; Britton WJ Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):136-41. PubMed ID: 8690972 [TBL] [Abstract][Full Text] [Related]
22. Survey of primary dapsone-resistant leprosy. Wang HY; Li WZ; Yang LH; Huang HS; Lu WQ; Yu LC Proc Chin Acad Med Sci Peking Union Med Coll; 1986; 1(3):173-5. PubMed ID: 3321049 [No Abstract] [Full Text] [Related]
23. [Advances in the chemotherapy of leprosy]. Grosset J Med Trop (Mars); 1984; 44(1):17-22. PubMed ID: 6377002 [TBL] [Abstract][Full Text] [Related]
24. Studies on risk of leprosy relapses in China: relapses after treatment with dapsone monotherapy. Chen XS; Li WZ; Jiang C; Ye GY Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):371-8. PubMed ID: 10700910 [TBL] [Abstract][Full Text] [Related]
25. Primary dapsone-resistant leprosy in San Francisco. Gelber RH Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):471-4. PubMed ID: 6399067 [TBL] [Abstract][Full Text] [Related]
26. [Prevalence of dapsone-resistant leprosy in Burundi. Temporary results]. Bourland J; Van Loo L; Pattyn SR Acta Leprol; 1982; (86-87):29-33. PubMed ID: 6815995 [No Abstract] [Full Text] [Related]
27. The clinical diagnosis of dapsone resistant leprosy. Taylor PM Lepr India; 1982 Jan; 54(1):117-22. PubMed ID: 7047897 [TBL] [Abstract][Full Text] [Related]
28. Prevalence of secondary dapsone resistance in Gudiyattam Taluk, the leprosy control area of the Schieffelin Leprosy Research and Training Centre, Karigiri. 1. Preliminary report. Balraj V; Jesudasan K; Chacko CJ; Christian M; Taylor PM; Fritschi EP; Job CK Int J Lepr Other Mycobact Dis; 1980 Dec; 48(4):397-401. PubMed ID: 7193654 [TBL] [Abstract][Full Text] [Related]
29. [Sulfone-resistance of Mycobacterium leprae--monotherapy with diaminodiphenylsulfone--the value of triple-drug combinations]. Floch HA Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):122-5. PubMed ID: 3519797 [TBL] [Abstract][Full Text] [Related]
30. Dapsone resistance in leprosy. Browne SG Trans St Johns Hosp Dermatol Soc; 1973; 59(2):225-9. PubMed ID: 4602407 [No Abstract] [Full Text] [Related]
31. [2 cases of paucibacillary leprosy resistant to dapsone]. Janssens L Acta Leprol; 1982; (86-87):181-3. PubMed ID: 6815986 [TBL] [Abstract][Full Text] [Related]
32. Letter: Dapsone dosage and drug resistance. Pfaltzgraff RE Lepr Rev; 1975 Sep; 46(3):235-8. PubMed ID: 1186417 [No Abstract] [Full Text] [Related]
33. Treatment of leprosy. Ramanujam K J Indian Med Assoc; 1973 Nov; 61(9):401-2. PubMed ID: 4791935 [No Abstract] [Full Text] [Related]
35. Problems of leprosy relapse in China. Li HY Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):1-7. PubMed ID: 8326169 [TBL] [Abstract][Full Text] [Related]
36. Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy. Cambau E; Carthagena L; Chauffour A; Ji B; Jarlier V Clin Infect Dis; 2006 Jan; 42(2):238-41. PubMed ID: 16355335 [TBL] [Abstract][Full Text] [Related]
38. Secondary sulphone resistance in leprosy (Report of a case). Lal S; Jaganath C; Garg BR; Paneerselvam R Lepr India; 1980 Apr; 52(2):299-301. PubMed ID: 7005542 [TBL] [Abstract][Full Text] [Related]
39. Relapse rates in patients treated with dapsone monotherapy and combinations of dapsone and thiambutosine, thiacetazone, isoniazid and streptomycin in the pre-MDT era. Smith TC; Richardus JH Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):353-8. PubMed ID: 7525795 [TBL] [Abstract][Full Text] [Related]